CD34 and acute myeloid leukemia: The percentage of peripheral blood (PB) CD34+ progenitors activated through NFκB activation was higher in AML patients (Supplementary Fig. S1G), as well as the nuclear translocation of the p50/p65 NFκB heterodimer (Fig. 1g; Supplementary Fig. S1H).